My watch list
my.bionity.com  
Login  

Oculyze receives investment boost

01-Apr-2019

Oculyze

Kilian Moser, co-founder and Chief Executive Officer of Oculyze

Oculyze announced that it had secured a seven figure investment from Constantia New Business (CNB) GmbH headquartered in Vienna, Austria. CNB is a venture capital investor working with high-tech startups inspired by the idea of creating impactful companies and joins Oculyze’s existing investor since 2017 BFB Brandenburg Kapital GmbH. The funds will be utilized to support Oculyze’s plans to grow the current business exponentially, specifically supporting late-stage research and development of additional products in the Oculyze portfolio and further market expansion both within Germany and across the world.

Commenting on the latest development, Kilian Moser, co-founder and Chief Executive Officer of Oculyze said: “As we embark on a new year, I am delighted to announce that we have secured further funding through a new partnership with Austrian based CNB. This latest funding comes at a very exciting time for Oculyze as we seek to consolidate and sustain our position as the world’s premier platform for mobile image analysis.

During 2018, we strengthened our core team through the hiring of senior professionals, bringing in a wealth of experience and expertise crucial to the future growth of Oculyze. In addition, and after developing and enhancing our technology, we rolled out our flagship product – the Oculyze Better Brewing (BB) 2.0 as well as signed on a global distribution partner to extend our product to an even bigger audience across the world. During the last quarter of 2018, we launched our online store, automating and streamlining the entire purchase-to-fulfillment process within a safe and secure environment. All these developments have resulted in a steady increase in sales and a customer reach across 26 countries.

We take this opportunity to thank the team at CNB for their invaluable support and will continue to focus on creating greater value for all our stakeholders.”

Speaking at the signing, Sabine Fleischmann, Senior Investment Manager at CNB said: “We are thrilled to collaborate with an innovative German firm like Oculyze as it looks to delivering on its vision to provide automated image analysis to anyone anywhere. As an independent Austrian venture capital investor, we are always on the look-out for innovative young companies across Europe that are backed by an experienced and professional team who fit our investment and business model and seek a partner to support them both financially and as a hands-on partner during the next growth stage. We are glad to extend our full support to them and look forward to a fruitful partnership”

Facts, background information, dossiers
  • image analysis
  • investments
More about Oculyze
  • News

    Oculyze & BIOTECON Diagnostics sign strategic partnership

    Oculyze and BIOTECON Diagnostics announced the signing of a strategic partnership. The agreement signed at the corporate offices of BIOTECON Diagnostics in Potsdam, appoints the Company as the exclusive global distributor of Oculyze’s latest technological innovation the Oculyze Better Brewi ... more

    Online marketing expertise for launching a company successfully

    There was more than one reason to celebrate for the Oculyze team, one of the winners of the competition "Science4Life Venture Cup 2016", on the evening of July 11. At the headquarters of the venerable Deutsche Bundesbank in Frankfurt, the awards were presented for the best business plans in ... more

  • Companies

    Oculyze GmbH

    Oculyze GmbH is a globally selling biotech firm and the world’s premier platform for mobile image analysis. Its cloud-based image analysis software transforms ordinary mobile devices into powerful tools enabling anyone to take a microscopic image and receive accurate and reproducible result ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE